Tag: innate
Innate Pharma: the CDC drops below 10%
(CercleFinance.com) – The Caisse des dépôts et consignations (CDC) declared to the AMF that it indirectly crossed downwards, on October 14, the threshold of 10% of the voting rights of…
Innate Pharma: still a long way to go…
By Claude Leguilloux Published on 09/23/2022 at 09:43 (Boursier.com) — Innate…
Innate Pharma: clinical activity and favorable safety profile of lacutamab – 09/23/2022 at 08:54
(AOF) – Innate Pharma announced that its anti-KIR3DL2 antibody, lacutamab, has established clinical responses in patients with mycosis fungoides in the Phase 2 Tellomak trial. “Therapeutic options are limited for…
Innate pharma: 6.3ME net profit in the 1st half
Read also (CercleFinance.com) – Innate Pharma today announces its first-half results. The company reports a cash position of €158.2 million as of June 30, 2022. The group made a net…
Innate pharma: Several presentations at the ESMO congress
Read also (CercleFinance.com) – Innate Pharma announced on Monday its intention to make several presentations at the ESMO congress, a conference devoted to oncology which will open at the end…
Innate Pharma: several presentations at the ESMO congress
(CercleFinance.com) – Innate Pharma announced on Monday its intention to make several presentations at the ESMO congress, a conference devoted to oncology which will open at the end of the…
Outstanding volumes today: Innate Pharma, Metabolic Explorer
During this trading session on Monday August 1, 2022, abnormal trading volumes were detected on the French market. Today, it is the Innate Pharma share that stands out, with trading…
Innate pharma: Stands out, a broker initiates the purchase
Read also (CercleFinance.com) – Innate Pharma shares rose sharply on the Paris Stock Exchange on Friday, driven by the initiation of hedging on the purchase by Stifel analysts. Around 3:30…
Innate pharma: Selection of a second antibody by Sanofi
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: towards a new study with Innate
(CercleFinance.com) – Innate Pharma announces that IPH5201, its monoclonal antibody directed against CD39, developed in partnership with AstraZeneca, will advance to a phase 2 clinical trial in lung cancer. The…
Innate Pharma: the cash position is 131.7 ME without the payment of AstraZeneca
By Alexandra Saintpierre Published on 05/10/2022 at 2:45 p.m. Photo credit © Reuters …
Unusual volumes on the stock market today: Innate Pharma
During this trading session on Friday April 29, 2022, abnormal trading volumes were detected on the French market. Today, it is the Innate Pharma share that stands out, with trading…